High-frequency electrical stimulation, and method of inhibiting pigment production by combined use of high-frequency electrical stimulation and cosmetic composition

The combination of 4-methoxysalicylic acid and radiofrequency treatment addresses the challenge of suppressing pigment formation and reducing age spots by decreasing senescent fibroblasts and increasing normal fibroblasts, achieving effective skin whitening in both the epidermis and dermis.

WO2024241918A1PCT designated stage expired Publication Date: 2024-11-28SHISEIDO CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/017447
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2024-05-10
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Current beauty methods fail to effectively suppress pigment formation and reduce age spots, as they are invasive or unable to directly act on dermal fibroblasts, and there is a lack of studies on using radiofrequency to decrease senescent fibroblasts and increase normal fibroblasts for skin whitening.

Method used

A method combining the application of 4-methoxysalicylic acid with radiofrequency (RF) to the skin, using a high-frequency beauty treatment device with electrodes and a control circuit to apply a high-frequency voltage, which suppresses pigment formation and reduces age spots by decreasing senescent fibroblasts and increasing normal fibroblasts, thereby achieving skin whitening in both the epidermis and dermis.

Benefits of technology

The combination of 4-methoxysalicylic acid and RF treatment effectively suppresses pigment formation, reduces age spots, and enhances skin whitening by decreasing senescent fibroblasts and increasing normal fibroblasts, providing a non-invasive and effective solution for skin whitening.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024017447_28112024_PF_FP_ABST
    Figure JP2024017447_28112024_PF_FP_ABST
Patent Text Reader

Abstract

Provided are a composition, a device, and a method for skin whitening. The present disclosure provides a cosmetic method based on a skin-whitening effect, or inhibition or reduction of skin blemishes through application of high-frequency waves and a cosmetic composition to the skin. The cosmetic method according to the present invention pertains to a cosmetic method for whitening of the skin in the epidermis and dermis, the method comprising: 1) applying a composition containing 4-methoxysalicylic acid to the skin; and 2) applying high-frequency waves to the skin.
Need to check novelty before this filing date? Find Prior Art

Description

High-frequency electrical stimulation and method for inhibiting pigment production by using high-frequency electrical stimulation and a cosmetic composition in combination

[0001] The present invention relates to a cosmetic method using high frequency waves, and more particularly to a method for suppressing or reducing spots or for whitening the skin.

[0002] Radio-frequency (RF) beauty treatments are known that can improve wrinkles and sagging skin by applying radio-frequency (RF) current to the skin of the face, hands, and feet. When RF current is applied to the skin, the temperature of the dermis and subcutaneous tissue rises. This heating effect is expected to promote blood flow and promote collagen regeneration in the dermis by thermally damaging the collagen in the dermis. In recent years, various beauty treatment devices utilizing such RF currents have been proposed (see, for example, Patent Document 1).

[0003] Patent Document 2 discloses a system and method for electrosurgical treatment of the skin. This document particularly discloses that a high-frequency voltage is applied to electrode terminals to raise the temperature of collagen fibers in the tissue at the target site from body temperature (approximately 37°C) to typically about 60°C to 70°C, thereby causing the collagen fibers to substantially irreversibly contract. The method disclosed in this document is used to cut, excise, ablate, or remove a certain volume of skin tissue or hair (i.e., to peel or dissociate molecules of tissue structure), separate a tissue layer from an underlying tissue layer, remove the tissue layer, contract or contact collagen connective tissue, and / or coagulate blood vessels below the surface of the skin, and is highly invasive to the subject.

[0004] Patent Document 3 discloses a cosmetic liquid agent penetration device and method, which describes that applying a pulse voltage to electrodes attached to the skin surface after the liquid agent has been applied can improve cosmetic effects.

[0005] Patent Document 4 discloses a radio-frequency cosmetic treatment device that can prevent localized heating of the skin. Patent Document 5 describes an RF-based skin treatment device that includes an RF generator that generates RF power, an applicator body, and a bipolar applicator that includes a needle disposed on the front surface of the applicator body, inserted into the dermis layer of the treatment recipient's skin, electrically connected to the RF generator, and transmitting the RF power. Patent Document 6 discloses a mask-shaped skin treatment device and system that includes a coupling agent detector configured to detect the presence of a coupling agent and a heating element configured to induce localized heating of a skin area. Locally increasing the skin temperature, such as by applying a mild thermal effect (40°C to 45°C) or a strong thermal effect (50°C to 90°C) to the dermis, can activate fibroblasts, increase collagen production, and cause collagen denaturation and contraction.

[0006] Patent Document 7 discloses a high-frequency treatment device consisting of a main body, a plate, a probe, a foot switch, and a band. It is stated that this high-frequency treatment device increases the elasticity of the skin, particularly by raising the temperature of the dermis layer to 50-60°C, promoting the contraction and production of collagen, and increasing the binding strength with elastin, thereby improving skin problems.

[0007] Patent document 8 discloses a novel pulse high frequency beauty device control system consisting of a sine wave high frequency power supply, a square wave driving power supply, a voltage pre-combustion module, a pulse generator, a high frequency generator, a liquid crystal display, a central processing unit, and a cooling water machine.

[0008] Patent Document 9 discloses a massage device that is simple in structure and easy to operate, and that not only achieves a facial slimming effect but also lifts and tightens the skin. However, no studies have been conducted to date on the application of high frequency waves to reduce the number of senescent fibroblasts and / or induce an increase in the number of normal fibroblasts, thereby suppressing pigmentation.

[0009] Japanese Patent Publication No. 2018-489 Japanese Patent Publication No. 2001-523513 Japanese Patent Publication No. 2007-319474 International Publication No. 2014 / 196195 Japanese Patent Publication No. 2021-533845 Japanese Patent Publication No. 2021-506517 Korean Patent Publication No. 10-2018-0047181 Chinese Patent Application Publication No. 105920732 Chinese Patent Application Publication No. 112426341 Japanese Patent Publication No. H06-40886

[0010] An object of the present invention is to provide a cosmetic method based on the suppression or reduction of dark spots or the whitening effect achieved by applying high frequency waves to the skin to provide physical stimulation. Another object of the present invention is to provide a cosmetic method based on the suppression or reduction of dark spots or the whitening effect achieved by applying high frequency waves and a cosmetic composition containing 4-methoxysalicylic acid to the skin.

[0011] According to one aspect of the present invention, there is provided a composition for whitening the epidermis and dermis of skin, which contains 4-methoxysalicylic acid as an active ingredient and is used in combination with a high-frequency treatment device.

[0012] Furthermore, one aspect of the present invention provides a cosmetic method for whitening the epidermis and dermis of skin, comprising: 1) applying a composition containing 4-methoxysalicylic acid to the skin; and 2) applying radio frequency waves to the skin.

[0013] Furthermore, according to one aspect of the present invention, there is provided a radio frequency cosmetic treatment device for use in a method for whitening skin, which comprises applying a composition containing 4-methoxysalicylic acid to the skin and applying radio frequency to the skin, the radio frequency cosmetic treatment device having a pair of electrodes and a control circuit that applies a radio frequency voltage to the pair of electrodes, and configured to apply a radio frequency voltage to the skin.

[0014] Furthermore, according to one aspect of the present invention, there is provided a method for operating a high-frequency cosmetic treatment device having a pair of electrodes and a control circuit that applies a high-frequency voltage to the pair of electrodes, the method including applying a high-frequency voltage to the pair of electrodes by the control circuit, the high-frequency voltage suppressing pigmentation in the skin, and the high-frequency voltage being applied while the pair of electrodes are in contact with the skin.

[0015] Furthermore, according to one aspect of the present invention, there is provided a method for operating a high-frequency cosmetic treatment device having a pair of electrodes and a control circuit that applies a high-frequency voltage to the pair of electrodes, the method comprising: applying a high-frequency voltage to the pair of electrodes by the control circuit that suppresses pigmentation in the skin; and the high-frequency voltage is applied while the pair of electrodes are in contact with skin to which a composition containing 4-methoxysalicylic acid has been applied.

[0016] Furthermore, according to one aspect of the present invention, a computer program is provided that causes an apparatus having a pair of electrodes and a control circuit that applies a high-frequency voltage to the pair of electrodes to execute the operating method of the high-frequency cosmetic processing apparatus disclosed herein.

[0017] Furthermore, according to one aspect of the present invention, there is provided a non-transitory computer-readable medium having stored thereon instructions, which, when executed by a processor, can execute a computer program that causes a method of operating a radio frequency cosmetic processing device according to the present disclosure to be performed.

[0018] Furthermore, according to one aspect of the present invention, there is provided a beauty kit for skin whitening, comprising a cosmetic composition containing 4-methoxysalicylic acid and a radio frequency cosmetic treatment device.

[0019] (Definition) In this specification, "application of high frequency" and "applying high frequency" mean passing a high frequency current through an object by applying a high frequency voltage between a pair of electrodes spaced apart and placed in contact with the object.

[0020] Furthermore, the word "about" used when indicating a numerical value means that the value modified by this word includes values ​​within 5% of the value.

[0021] According to the present invention, it is possible to bring about a whitening effect in the epidermis and dermis of the skin.

[0022]

[0033] FIG. 1 is a block diagram showing one embodiment of a high-frequency device that can be used in the present invention.

[0034] FIG. 1 is a photograph showing cell proliferation after RF application to PUVA-treated fibroblasts (Fb). RF-: No RF application; RF+: RF application at a frequency of 1 MHz / voltage level of 70 Vpp / output pattern of 4 seconds on and 4 seconds off; RF++: RF application at a frequency of 950 kHz / voltage level of 168 Vpp / output pattern of 1 second on and 2 seconds off.

[0035] FIG. 1 is a graph quantifying cell proliferation after RF application to PUVA-treated fibroblasts (Fb). Relative values ​​are shown relative to RF-.

[0036] FIG. 1 is a photograph showing cell proliferation after RF application to non-PUVA-treated fibroblasts (Fb). RF-: No RF application; RF+: RF application at a frequency of 1 MHz / voltage level of 70 Vpp / output pattern of 4 seconds on and 4 seconds off; RF++: RF application at a frequency of 950 kHz / voltage level of 168 Vpp / output pattern of 1 second on and 2 seconds off. Graph quantifying cell proliferation after application of RF to non-PUVA-treated fibroblasts (Fb). Relative values ​​relative to RF- are shown. Photograph showing the number of p21-positive fibroblasts (Fb) after RF application. Graph quantifying the number of p21-positive Fb cells after RF application. Relative values ​​relative to RF- are shown. Graph quantifying the amount of melanin in an epidermal model co-cultured with RF-stimulated PUVA-treated fibroblasts. Relative values ​​relative to RF- are shown. Graph showing the results of RT-PCR analysis of gene expression of TYR, TYRP1, DCT, and MITF in an epidermal model co-cultured with RF-stimulated PUVA-treated fibroblasts. Relative values ​​relative to RF- are shown. Graph quantifying the amount of melanin in an epidermal model co-cultured with RF-stimulated PUVA-treated fibroblasts. Relative values ​​relative to RF- are shown. Graph quantifying the amount of melanin in an epidermal model co-cultured with RF-stimulated PUVA-treated fibroblasts. Relative values ​​relative to RF- are shown. Graph quantifying the amount of melanin in an epidermal model co-cultured with RF-stimulated PUVA-treated fibroblasts. Relative values ​​relative to RF- are shown.This figure shows the results of an investigation into the effect of adding normal fibroblasts to epidermal cells in pseudo-blemish areas, in which PUVA-treated fibroblasts were co-cultured with non-PUVA-treated or PUVA-treated fibroblasts and normal fibroblasts were added at a ratio of 1:1 / 10, 1:1 / 5, 1:1 / 2, and an equal amount. This figure shows photographs showing color tone. This figure shows graphs quantifying melanin levels in epidermal models co-cultured with non-PUVA-treated or PUVA-treated fibroblasts and normal fibroblasts were added at a ratio of 1:1 / 10, 1:1 / 5, 1:1 / 2, and an equal amount. Values ​​are shown relative to non-PUVA-treated fibroblasts. This figure shows photographs showing color tone in epidermal models co-cultured with PUVA-treated fibroblasts and RF application, with and without the addition of 4-methoxysalicylic acid (control) 3 days after PUVA treatment. This graph quantifies the amount of melanin in an epidermal model co-cultured with fibroblasts 3 days after PUVA treatment, with and without the addition of 4-methoxysalicylic acid (control) after RF application. This graph shows the results of temperature measurements on fresh PUVA-treated skin (NSA11) with RF+ stimulation. This graph shows the results of temperature measurements on fresh PUVA-treated skin (NSA11) with RF++ stimulation. This graph shows the results of temperature measurements on fresh PUVA-treated skin (NSA11) with and without RF application (dH). 2 Photographs showing the color tone in the presence of 1% 4MSK (RF-PBS) and 4-methoxysalicylic acid (RF++) treatments are shown. Fontana-Masson stained images of fresh PUVA-treated skin (NSA11) in the following cases: control (with PBS) without RF application (RF-PBS: upper left), with 4-methoxysalicylic acid added without RF application (RF-1% 4MSK: upper right), with 4-methoxysalicylic acid added after RF+ application (RF+1% 4MSK: lower left), and with 4-methoxysalicylic acid added after RF++ application (RF++1% 4MSK: lower right). This graph quantifies the amount of melanin in fresh PUVA-treated skin (NSA11) in the following cases: control (PBS added) without RF application (Control: first from the left), with 4-methoxysalicylic acid added without RF application (4MSK: second from the left), with 4-methoxysalicylic acid added after RF+ application (RF+_4MSK: second from the right), and with 4-methoxysalicylic acid added after RF++ application (RF++_4MSK: first from the right).

[0023] One of the causes of age spots is thought to be a chronic abnormal aging state of dermal fibroblasts. Conventional cosmetics and laser treatments have had difficulty directly acting on the dermis. Furthermore, conventional high-frequency cosmetic methods, such as those described in Patent Document 2, involve cutting, excising, peeling, or removing a certain volume of skin tissue or hair (i.e., peeling or dissociating molecules of tissue structures), separating a tissue layer from an underlying tissue layer, removing the tissue layer, contracting or contacting collagen connective tissue, and / or coagulating blood vessels beneath the surface of the skin, which are highly invasive to the target.

[0024] An object of the present invention is to provide a cosmetic method based on the suppression or reduction of blemishes or the whitening effect obtained by applying high frequency waves to the skin to provide physical stimulation. Another object of the present invention is to provide a cosmetic method based on the suppression or reduction of blemishes in the epidermis and dermis of the skin or the whitening effect obtained by applying a cosmetic composition containing 4-methoxysalicylic acid and high frequency waves to the skin.

[0025] The present invention is based on the new finding of the inventors that application of radio frequency (RF) to the skin significantly contributes to the inhibition of pigmentation by skin cells. As one aspect of the present invention, there are provided a cosmetic method comprising applying RF to the skin to inhibit or reduce blemishes or to whiten the skin, and a cosmetic method comprising applying RF to the skin to inhibit pigmentation.

[0026] The present invention is based on the new finding of the present inventors that applying a combination of 4-methoxysalicylic acid and radiofrequency (RF) to the skin further enhances the effect of radiofrequency (RF) in suppressing pigmentation by skin cells. One aspect of the present invention provides a cosmetic method for suppressing pigmentation in the skin, suppressing or reducing age spots, and particularly whitening the epidermis and dermis of the skin, by 1) applying 4-methoxysalicylic acid to the skin, and 2) applying radiofrequency to the skin.

[0027] In one aspect, skin lightening in the dermis is achieved by reducing the number of senescent fibroblasts and / or increasing the number of normal fibroblasts. The senescent fibroblasts may be p21-positive cells. Skin blemishes may be improved by reducing the number of senescent fibroblasts (which may be identified as p21-positive cells) and / or increasing the number of normal fibroblasts. In one aspect, skin lightening is achieved in both the epidermis and dermis of the skin by applying 4-methoxysalicylic acid and radiofrequency.

[0028] Furthermore, some aspects of the present invention also relate to a high frequency cosmetic treatment device, a cosmetic composition, and a cosmetic kit used in carrying out the cosmetic method.

[0029] The frequency of the radio frequency applied to the skin may be in the range of 0.5 MHz to 4 MHz, for example, 0.5 MHz, 0.95 MHz, 1 MHz, 2 MHz, 3 MHz, or 4 MHz, or any frequency within the range defined by any of the above frequencies (e.g., the range of 1 to 4 MHz). In some embodiments of the present invention, the frequency is about 1 MHz.

[0030] The application of high frequency to the skin may be combined with the application of drugs or various extracts to the skin. For example, applicable drugs and various extracts include ginseng extract, inositol, retinol derivatives, xylitol, hyaluronic acid, glycerin, yeast extract, cherry leaf extract, cinnamon extract, pine extract, Bulgarian rose water, okra extract, musk extract, burnet extract, dipotassium glycyrrhizinate, ginkgo leaf extract, Chinese tea extract, coix seed extract, licorice extract, sophora flavescens extract, star fruit leaf extract, and Niacin. Examples include ginseng extract, herb extract, neem leaf extract, saffron extract, cinchona extract, comfrey extract, thyme extract, winter strawberry, yomena, Mube, Ryukyu strawberry, Indian yomena, edulis oak, Scutellaria root extract, rosemary extract, apricot kernel, gentian extract, peppermint powder, taiso extract, hop extract, kiwi extract, Roman chamomile extract, apple extract, hawthorn extract, turmeric extract, bayberry, myrtaceae, and oak. These can be used alone or in combination. When each ingredient is incorporated into a cosmetic or quasi-drug, the amount of each ingredient can be, for example, 0.00001 to 0.5% by mass.

[0031] The 4-methoxysalicylic acid used in the present invention can be easily synthesized by known methods such as those described in Patent Document 10. In addition, it is commercially available as a reagent from Aldrich (Germany) and other companies, and this can also be used (Patent Document 10).

[0032] 4-Methoxysalicylic acid can be converted into a salt by known methods and may be incorporated in the composition of the present invention in the form of a salt. Examples of such salts include, but are not limited to, alkali metal salts or alkaline earth metal salts such as sodium salt, potassium salt, and calcium salt, as well as ammonium salts and amino acid salts.

[0033] The amount of 4-methoxysalicylic acid and / or its salt is preferably 0.001 to 20% by weight, more preferably 0.01 to 10% by weight, e.g., 0.1 to 5.0% by weight, or 1.0% by weight, based on the total amount of the composition of the present invention. If the amount is less than 0.001% by weight, the whitening effect is poor, and if the amount exceeds 20% by weight, the whitening effect levels off, and no increase in effect commensurate with the increase in amount can be expected.

[0034] 4-Methoxysalicylic acid is known to have a whitening effect on skin epidermal cells, but its application to the skin in combination with radiofrequency (RF) is preferred because it further enhances the effect of radiofrequency (RF) in suppressing pigmentation by skin cells, thereby achieving whitening in both the epidermis and dermis of the skin.

[0035] In some embodiments of the present invention, the composition to be applied to the skin in combination with radiofrequency radiation contains 4-methoxysalicylic acid. That is, one aspect of the present invention relates to a cosmetic composition containing 4-methoxysalicylic acid as an active ingredient for use in combination with a radiofrequency cosmetic treatment device, the cosmetic composition being for inhibiting pigmentation, inhibiting or reducing age spots, or whitening the skin, particularly a composition for whitening the epidermis and dermis of the skin.

[0036] The cosmetic composition according to the present disclosure may be in the form of an emulsion, cream, serum, lotion, pack, facial cleanser, soap, body soap, shampoo, etc., and may be in various forms such as liquid, emulsion, cream, solid, sheet, spray, gel, or foam. However, the forms that the present invention can take are not limited to these forms. Furthermore, the composition according to the present disclosure may contain additives such as excipients, colorants, thickeners, binders, disintegrants, dispersants, stabilizers, gelling agents, antioxidants, surfactants, preservatives, pH adjusters, oils, water, alcohols, chelating agents, silicones, UV absorbers, moisturizers, fragrances, various medicinal ingredients, preservatives, and neutralizing agents.

[0037] The application of the cosmetic composition and the high frequency radiation to the skin can be carried out in any order and at any time interval. For example, the application of the high frequency radiation can be carried out almost simultaneously with or immediately after the application of the composition, for example, within 5 seconds, 10 seconds, 30 seconds, 1 minute, 3 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 2 hours, 3 hours, or 6 hours after the application of the composition.

[0038] A high frequency device can be used to apply high frequency waves to the skin. One form of the high frequency device will be described with reference to FIG.

[0039] The high-frequency device 1 includes an electrode unit 10 and a control circuit 20. The electrode unit 10 includes a first electrode 10a and a second electrode 10b connected to the control circuit 20. The electrode unit 10 is provided with a contact surface that contacts the user's skin, and the first electrode 10a and the second electrode 10b are arranged on this contact surface at a distance from each other, so that the first electrode 10a and the second electrode 10b can be easily brought into contact with the skin at a distance from each other. The first electrode 10a and the second electrode 10b may be connected to the control circuit 20 via a wiring cable rather than via the contact surface, allowing the first electrode 10a and the second electrode 10b to be arranged freely.

[0040] The control circuit 20 may include a power supply unit, a voltage control unit, and a resistance measurement unit. The power supply unit applies a high-frequency voltage (a voltage indicating high frequency) between the first electrode 10a and the second electrode 10b. The power supply unit includes an oscillator circuit for generating the high-frequency voltage and a booster circuit for boosting the oscillated voltage, and is configured to apply a high-frequency voltage of, for example, approximately 0.5 MHz to 4 MHz between the first electrode 10a and the second electrode 10b. By applying a high-frequency voltage between the first electrode 10a and the second electrode 10b while the first electrode 10a and the second electrode 10b are in contact with the user's skin, a high-frequency current can be passed through the skin. The application of high-frequency waves can be non-invasive, for example, by contacting the electrode with the skin surface. For example, the application of high-frequency waves can be performed by contacting the electrode perpendicular to the skin and moving it so that the tip of the electrode touches the skin. The electrode movement speed can be, for example, approximately 2 cm per second.

[0041] The voltage control unit controls the power supply unit to control the high-frequency voltage applied by the power supply unit. The voltage control unit also uses the measurement results from the resistance measurement unit to control the voltage. The resistance measurement unit measures the resistance value (electrical resistance value) between the first electrode 10a and the second electrode 10b when the first electrode 10a and the second electrode 10b are in contact with the user's skin.

[0042] This resistance value varies depending on the user's skin condition and the type of topical skin preparation, such as a skin lotion, applied to the skin. For example, when a high-frequency current is applied to human skin, the skin heats up, and as the skin temperature rises, the impedance inside the skin decreases. Therefore, as the skin temperature rises, the current flowing between the first electrode 10a and the second electrode 10b increases, and the measured resistance value decreases. The resistance measurement unit measures the resistance value at a predetermined time interval (e.g., every 0.5 seconds) and supplies the measured resistance value to the voltage control unit each time. In the method disclosed herein, the skin temperature rise can be set to remain below 45°C or 40°C, for example.

[0043] The voltage control unit controls the high frequency voltage according to the resistance value measured by the resistance measurement unit, for example, so that the higher the measured resistance value, the higher the high frequency voltage (the larger the amplitude of the high frequency voltage).

[0044] The lower limit of the high-frequency voltage applied between the first electrode 10a and the second electrode 10b is preferably 50 Vpp or more, more preferably 70 Vpp or more, in peak-to-peak voltage. The upper limit of the high-frequency voltage applied between the first electrode 10a and the second electrode 10b is preferably 200 Vpp or less, more preferably 170 Vpp or less, in peak-to-peak voltage. The applied high-frequency voltage can be, for example, 70 Vpp.

[0045] The high-frequency voltage may be applied continuously or in pulses. In the case of pulse application, the application (ON) and non-application (OFF) of the high-frequency voltage are repeated periodically. The period of the repeated pulse application may be 0.1 to 10 seconds, for example, 0.1, 0.2, 0.3, 0.5, 0.8, 1, 1.2, 2, 3, 4, 5, 6, 7, 8, 9, or 10 seconds. The duty ratio, which is the ON time ratio of the high-frequency voltage in the pulse application, is preferably in the range of 10% to 99%, and more preferably in the range of 20% to 80%. The duty ratio may be, for example, 40%.

[0046] The application conditions of the high frequency, such as the high frequency voltage and duty ratio, may be user-configurable. To enable the user to set the application conditions of the high frequency, the high frequency device may have an input device operated by the user. Any device, such as a switch, may be used as the input device. When the application conditions of the high frequency are user-configurable, the control circuit 20 receives input operations through the input device and controls parameters such as the high frequency voltage, whether the application is continuous or pulsed, and the period and duty ratio in the case of pulsed application, according to the received input operations. When setting the application conditions of the high frequency, each parameter may be independently configurable, or multiple combinations of the high frequency voltage, period, and duty ratio for pulsed application may be preset in the control circuit 20, and the user may select one of the preset combinations.

[0047] As described above, a high-frequency cosmetic treatment device having a pair of electrodes and a control circuit for applying a high-frequency voltage to the pair of electrodes and configured to apply a high-frequency voltage to the skin that suppresses skin pigmentation can be used to easily apply high-frequency waves to a user's skin. The high-frequency treatment device can be operated as follows: First, the first electrode 10a and the second electrode 10b are placed in contact with the user's skin at a distance from each other. Next, the control circuit 20 applies a high-frequency voltage between the first electrode 10a and the second electrode 10b placed in contact with the user's skin so as to increase the stability of dermal stem cells. By applying high-frequency waves to the skin in this manner, pigmentation in the skin can be suppressed, and the suppression or reduction of age spots or a whitening effect can be achieved.

[0048] The above-described operating method can be controlled by executing a computer program. The computer program according to the present disclosure may be stored on a non-transitory computer-readable medium. Instructions defined by the computer program are executed by a processor such as a CPU. The CPU can control the overall processing of the computer, such as various calculations and data input / output with each hardware component, based on a control program such as an OS (operating system) and an execution program stored in a memory device, thereby achieving each process. The memory device can store the execution program read from the auxiliary storage device by the CPU. The memory device may be composed of a ROM (read-only memory) or RAM (random access memory). The auxiliary storage device is a storage means such as a hard disk, and can store the execution program according to the present disclosure and control programs installed in the computer, and can input / output data as needed. Various information required during program execution can be obtained from the auxiliary storage device, and execution results can also be stored. The execution program may be downloaded, in whole or in part, from an external device via any network as needed. Furthermore, the external device may be equipped with an auxiliary storage device into which the execution program is installed and / or a memory device that stores the installed execution program. The external device may be a server. The server may be a specific server, or an unspecified server such as a cloud platform. Furthermore, the executable program may be provided through a subscription-based service. A subscription-based service is a form of computer software usage in which fees are paid according to the period of software usage. In this way, the form of use of the executable program may be any and is not limited.

[0049] One aspect of the present invention relates to a radiofrequency device for use in combination with applying a composition containing 4-methoxysalicylic acid to the skin, for inhibiting pigmentation, inhibiting or reducing age spots, or whitening the skin.

[0050] One aspect of the present invention relates to a beauty kit including a cosmetic composition containing 4-methoxysalicylic acid and a radio-frequency cosmetic treatment device. The beauty kit can be used for inhibiting pigmentation in the skin, inhibiting or reducing age spots, or whitening the skin. The cosmetic composition is contained in, for example, a bottle. The beauty kit may also include instructions describing how to use the composition and the radio-frequency treatment device.

[0051] [Confirmation of Improvement in Stability of Dermal Stem Cells by Application of High Frequency] Hereinafter, an experiment conducted by the inventors to confirm the suppression, reduction, and improvement of dark spots by application of high frequency will be described.

[0052] 1-1 Epidermal Cell Culture Normal human epidermal melanocytes (Kurabo) were cultured in Medium 254 (Thermo Fisher Scientific) supplemented with human melanocyte growth supplement (HMGS-2). Normal human epidermal keratinocytes (Kurabo) were cultured in Epilife® medium (Thermo Fisher Scientific) containing 60 μM calcium and keratinocyte growth supplement (EDGS).

[0053] [1-2 Fibroblast (Fb) Culture and PUVA Treatment] Normal human fibroblasts (Cell Research Corp.) were cultured in Dulbecco's Modified Eagle Medium (10% DMEM) containing 10% fetal bovine serum, and 3 × 10 cells were cultured in a T25 flask. 5 Before the cell density reached 100% confluence, the medium was replaced with 10% DMEM supplemented with the photosensitizer psoralen (final concentration 25 ng / mL) and cultured. After 24 h, the cells were swollen with 4 mL of PBS, removed, and replaced with 1 mL of PBS supplemented with psoralen (final concentration 25 ng / mL), at a dose of 6 J / cm. 2The cells were then irradiated with UVA (hereafter referred to as PUVA treatment). After swelling with 4 mL of PBS, the PBS was removed and replaced with 10% DMEM. The cells were then cultured for 3 days, and the culture supernatant and cells were collected. PUVA-untreated fibroblasts from the same donor served as a control for the PUVA-treated fibroblasts.

[0054] [1-3 RF irradiation] Fibroblasts cultured by the above method, either 3 days after PUVA treatment or untreated, were placed in a culture jig equipped with electrodes at 1 × 10 5 Before the cells reached 80% confluence, two types of high-frequency devices ([RF+] frequency: 1 MHz / voltage level: 70 Vpp / output pattern: RF applied for 4 seconds on, 4 seconds off; [RF++] frequency: 950 kHz / voltage level: 168 Vpp / output pattern: RF applied for 1 second on, 2 seconds off) were connected to the electrodes of the jig, and RF stimulation was applied for 3 minutes with each. After culturing for 3 days, the culture supernatant and cells were collected.

[0055] [1-4 Cell viability assay] Two ml of DMEM supplemented with 10% Alamar Blue reagent (Thermo Fisher Scientific Inc.) was added directly to each fibroblast culture device, and the cells were further cultured at 37°C for 4 hours in the dark. After culture, the medium was collected and measured at OD570nm and OD600nm to determine the fluorescence intensity emitted by the cells.

[0056] [1-5 Creation of three-dimensional culture models of epidermal cells and fibroblasts] Three days after PUVA treatment, or after RF stimulation, untreated fibroblasts were cultured in 24-well plates at 3 × 10 4 The cells were seeded and cultured for approximately 24 hours to allow the cells to adhere. The three-dimensional epidermal model was created by seeding epidermal cells onto a 24-well culture insert and culturing them. Keratinocytes and melanocytes were seeded onto the culture insert at a ratio of 10:1 to create the epidermal layer. The keratinocytes and melanocytes were each 1×10 5 cells / cm 2 and 1×10 6 cells / cm 2The cells were seeded at a density of 1000 x g. After culturing for three days, when the cells reached confluence, the epidermal layer was exposed to the gas phase while the culture medium was placed on the outside of the insert membrane. At the start of liquid-phase culture of the epidermal model, the culture insert was moved onto fibroblasts pre-seeded in a 24-well plate, and co-culture was carried out for 14 days (see also WO2020 / 111265, incorporated herein by reference). After the culture was completed, the color of the model was evaluated visually and by melanin quantification. The three-dimensional skin model was cultured in a 1:1:1 mixture of 10% DMEM (fibroblast culture medium), M254 (melanocyte culture medium), and EpiLife (keratinocyte culture medium).

[0057] [1-6 Immunoantibody Staining] The medium was removed from the cell-seeded chamber slide, washed with PBS, and then 4% paraformaldehyde (Wako) was added and allowed to stand at room temperature for approximately 1 hour to fix the cells. After three washes with PBS, 1 mL of Immunoblock® (DS Pharma Biomedical Co., Ltd.), a blocking agent for immunological experiments, was added per well and allowed to stand at room temperature for 1 hour. After three washes with PBS, the primary antibody p21 (Abcam) was diluted 1:100 in diluent (1% BSA-PBS) and added to the fixed cells, followed by overnight incubation at 4°C. After three PBS washes, the secondary antibody Alexa Fluor® 488 (Abcam) was diluted 1:1000 and added to the fixed cells, followed by incubation at room temperature for 1 hour. After washing again three times with PBS, 500 μl of 0.1% Hoechst® 33342 (Thermo Fisher Scientific Inc.)-PBS solution was added, and the cells were incubated at 37°C, 5% CO 2 The cells were incubated under 5% CO2 for 15 minutes under 5% CO2 conditions to stain the cell nuclei. After washing three times with PBS, the cells were observed under a microscope and images were taken. Immunofluorescent staining results were observed using an LSM700 laser scanning confocal microscope, and images were acquired using Zen2011 software (Carl Zeiss, Thornwood, NY, USA). The percentage of p21-positive cells was quantified using the image analysis software ImageJ (NIH). Representative images are shown after four independent experiments.

[0058] [1-7 RT-PCR] Total RNA was extracted using the RNeasy Mini Kit (Qiagen). 200 ng of total RNA was reverse transcribed using the PrimeScript RT Reagent Kit (Takara). PCR was performed using the PrimeScript RT-PCR Kit (Takara). Gene expression of MITF, TYR, TYRP1, and DCT in keratinocytes after fibroblast treatment was analyzed by RT-PCR assay. PCR results were obtained from three independent experiments. The sequences of the PCR primers are shown below.

[0059]

[0060] [1-8 Creation of a 3D culture model of epidermal cells and fibroblasts treated with 4-methoxysalicylic acid] Fibroblasts 3 days after PUVA treatment and untreated fibroblasts were mixed at a ratio of 10:1 and placed in a culture device equipped with electrodes at a density of 3 × 10 4 Cells were seeded onto the fibroblasts. After culturing for 24 hours to allow the fibroblasts to adhere, a melanocyte-containing epidermal model MEL-300 (Kurashiki Boseki Co., Ltd.) was placed on the culture jig and co-cultured for an additional 14 days. PBS or 1.0 wt% 4-methoxysalicylic acid was applied to the epidermis, and PBS was washed and reapplied every two days. RF was applied once every three days, with the epidermal model removed from the culture jig and only the fibroblasts irradiated. After culturing, the color of the model was evaluated visually and by melanin quantification. The three-dimensional skin model was cultured in the epidermal model culture maintenance medium EPI-LLMM (Kurashiki Boseki Co., Ltd.).

[0061] [1-9 RF irradiation] PUVA-treated fibroblasts cultured by the above method for 3 days and untreated fibroblasts were mixed at a ratio of 10:1, and 1 × 10 cells were placed in a culture jig equipped with an electrode. 5Before the cells reached 80% confluence, two types of high-frequency devices ([RF+] frequency: 1 MHz / voltage level: 70 Vpp / output pattern: RF applied for 4 seconds on and 4 seconds off, [RF++] frequency: 950 kHz / voltage level: 168 Vpp / output pattern: RF applied for 1 second on and 2 seconds off) were connected to the electrodes of the jig, and RF stimulation was applied for 3 minutes with each device.

[0062] [1-10 Immunoantibody staining] 5 × 10 fibroblasts were irradiated with RF and cultured for 24 hours using the method described above. 3 Cells were seeded onto chamber slides. The medium was removed from the chamber slides. After washing with PBS, 4% paraformaldehyde (Wako) was added and the cells were fixed by incubating at room temperature for approximately 1 hour. After three washes with PBS, 1 mL of Immunoblock® (DS Pharma Biomedical Co., Ltd.), a blocking agent for immunological experiments, was added per well and incubated at room temperature for 1 hour. After three further washes with PBS, the primary antibody p21 (Abcam) was diluted 1:100 in diluent (1% BSA-PBS) and added to the fixed cells. The cells were then incubated overnight at 4°C. After three PBS washes, the secondary antibody Alexa Fluor® 488 (Abcam) diluted 1:1000 was added to the fixed cells and incubated at room temperature for 1 hour. After washing again three times with PBS, 500 μl of 0.1% Hoechst® 33342 (Thermo Fisher Scientific Inc.)-PBS solution was added, and the cells were incubated at 37°C, 5% CO 2 The cells were incubated under 5% CO2 for 15 minutes under 5% CO2 conditions to stain the cell nuclei. After washing three times with PBS, the cells were observed under a microscope and images were taken. Immunofluorescent staining results were observed using an LSM700 laser scanning confocal microscope, and images were acquired using Zen2011 software (Carl Zeiss, Thornwood, NY, USA). Cell counts and the proportion of p21-positive cells were quantified using the image analysis software ImageJ (NIH). Representative images are shown after four independent experiments.

[0063] [1-11 Measurement of Intracellular Melanin Content] Melanocytes or three-dimensional skin models were harvested and centrifuged (4°C, 2,300 g, 5 min). 120 μl of 0.2 N NaOH was added to the resulting cell mass, and the cells were incubated in a water bath at 80°C for 30 minutes to extract intracellular melanin. The resulting supernatant was measured at OD 405 nm, and this was used as the intracellular melanin content. The melanin content was quantified using a calibration curve prepared with synthetic melanin (Sigma Aldrich, St. Louis, MO, USA) and then normalized by protein content. Results were obtained from three independent experiments.

[0064] [1-12 Ex vivo PUVA treatment of fresh skin and temperature distribution measurement] Fresh skin (NSA11) was purchased from Genoskin. 1 mL of PBS containing the photosensitizer psoralen (final concentration 0.5 μg / mL) was added to the top of the skin, which was then left to stand in an incubator for 30 minutes, after which the solution was removed with a cotton swab. Afterwards, 6 J / cm 2 The tissue was then exposed to UVA (hereafter referred to as PUVA treatment) and incubated for 24 hours. RF irradiation (RF+: frequency 1 MHz, voltage 70 Vpp; RF++: frequency 950 kHz, voltage 168 Vpp) was performed using two types of high-frequency devices connected to electrodes set at 3 mm width, and stimulation was applied from the upper surface of the skin for 3 minutes. During irradiation, images were taken with a thermographic camera (Optris), and temperature distribution images were obtained using the accompanying software, PIX Connect.

[0065] [1-13 Preparation and staining of tissue sections] After RF irradiation, the control dH 2O or 4-methoxysalicylic acid was added to the top and incubated for another 24 hours. This RF irradiation and extract addition cycle was repeated for three days, after which skin samples were harvested. Skin samples were fixed in 4% PFA overnight at 4°C and embedded in paraffin. Paraffin sections (5 μm) were prepared, deparaffinized, and then subjected to Fontana-Masson staining. After immersion in Fontana ammoniacal silver solution (Muto Chemical) for one hour, they were then immersed in 0.2% gold chloride (Muto Chemical) for five seconds to stain for melanin. After mounting, the sections were photographed and visualized to confirm changes in the localization and quantity of melanin with and without stimulation. Changes in the number of senescent fibroblasts due to PUVA treatment were evaluated by immunofluorescence staining. Deparaffinized slides were subjected to antigen retrieval and permeabilization. After washing three times with TBS, 10% goat serum (Nichirei Biosciences) was added and blocked for one hour at room temperature. After three further washes with TBS, primary antibodies p21 (Abcam) and vimentin (Abcam) were diluted 1:100 in diluent (1% BSA-TBS) and applied to the slides for 1 hour at room temperature. After three TBS washes, secondary antibodies Alexa Fluor® 488 and Alexa Fluor® 594 (Abcam) were diluted 1:1000 and applied to the slides for 1 hour at room temperature. After another three washes with TBS, the slides were mounted with DAPI-containing Fluoro-KEEPER Antifade Reagent (Nacalai Tesque, Inc.) for fluorescence microscopy and imaging. Immunofluorescent staining results were observed using an LSM700 laser scanning confocal microscope, and images were captured using Zen2011 software (Carl Zeiss, Thornwood, NY, USA). Representative images are shown from four independent experiments.

[0066] [1-14 Statistical Processing] Statistical processing was performed using Graph Pad Prism 5 (Graph Pad Software, La Jolla, CA) with one-way analysis of variance. A p<0.05 was considered to indicate statistical significance, and the degree of significance is indicated by the following asterisks: (*p<0.05, **p<0.01, ***p<0.001). All experiments were repeated at least three times to confirm reproducibility.

[0067] [2-1 RF irradiation reduces dermal senescence fibroblast proliferation, which is one of the root causes of pigmentation] Fibroblasts 3 days after PUVA treatment were cultured in a culture jig equipped with electrodes at a concentration of 1 × 10 5 Cells were seeded. Before the cell density reached 80% confluence, two types of radiofrequency devices (RF+: frequency 1 MHz, voltage 70 Vpp; RF++: frequency 950 kHz, voltage 168 Vpp) were connected to the electrodes of the jig, and RF stimulation was applied for 3 minutes with each. The results of examining the cells after 3 days of culture are shown in Figures 2-1 and 2-2. The results demonstrated that RF irradiation reduces the proliferation of senescent dermal fibroblasts, one of the root causes of pigmentation.

[0068] [2-2 RF promotes the increase of normal Fb] PUVA-untreated fibroblasts were cultured in a culture jig equipped with electrodes at 1 × 10 5 Cells were seeded. Before the cell density reached 80% confluence, two types of radiofrequency devices (RF+: frequency 1 MHz, voltage 70 Vpp; RF++: frequency 950 kHz, voltage 168 Vpp) were connected to the electrodes of the jig, and RF stimulation was applied for 3 minutes with each. The results of examining the cells after 3 days of culture are shown in Figures 3-1 and 3-2. The results demonstrated that RF promotes the proliferation of normal fibroblasts (RF selectively removes only senescent Fb).

[0069] [2-3 RF irradiation is mainly involved in the removal of stagnant Fb due to accelerated senescence] Fibroblasts 3 days after PUVA treatment were cultured in a culture jig equipped with electrodes at a concentration of 1 × 10 5Cells were seeded. Before the cell density reached 80% confluence, two types of radiofrequency devices (RF+: frequency 1 MHz, voltage 70 Vpp; RF++: frequency 950 kHz, voltage 168 Vpp) were connected to the electrodes of the jig, and RF stimulation was applied for 3 minutes with each. The results of examining the cells after 3 days of culture are shown in Figures 4-1 and 4-2. The image analysis software ImageJ (NIH) was used to quantify the proportion of p21-positive cells from photographs of the cells. The results revealed that RF irradiation was primarily involved in the removal of fibroblasts (p21-positive cells) that had undergone accelerated senescence and were in a stagnant state.

[0070] [2-4 RF irradiation suppresses pigmentation via the phenomenon of senescent Fb] Fibroblasts treated with PUVA for 3 days were RF-stimulated and co-cultured with an epidermal model for 14 days. After the culture period, the color of the model was evaluated visually and by melanin quantification, and it was found that RF treatment reduced the amount of melanin (Figure 5-1). Furthermore, analysis of gene expression of TYR, TYRP1, DCT, and MITF by RT-PCR revealed that RF treatment significantly reduced gene expression of TYR, TYRP1, and DCT (Figure 5-2).

[0071] [2-5 RF irradiation inhibits pigmentation by targeting senescent Fb, while RF irradiation induces proliferation of normal Fb but does not contribute to pigmentation alone] Fibroblasts treated with PUVA for three days or untreated fibroblasts given RF stimulation were co-cultured with an epidermal model for 14 days. After the culture was completed, the color of the model was evaluated visually and by melanin quantification. It was revealed that RF treatment reduced the amount of melanin in PUVA-treated senescent Fb cells, but RF treatment had no effect on the amount of melanin in untreated normal Fb cells (Figures 6-1 and 6-2).

[0072] [2-6 The higher the ratio of normal fibroblasts to senescent fibroblasts (PUVA Fb), the greater the whitening effect.] After co-culture of PUVA-treated fibroblasts with the epidermal model for 3 days, normal fibroblasts were added to the initially seeded PUVA-treated fibroblasts at 1:1 / 10, 1:1 / 5, 1:1 / 2, or an equal amount. The cells were then cultured for an additional 10 days to examine the effect of adding normal fibroblasts to epidermal cells in areas with pseudo-blemishes. After the culture was completed, the color of the epidermal model was evaluated visually and by melanin quantification (Figures 7-1 and 7-2). It was found that the higher the ratio of normal fibroblasts to senescent fibroblasts (PUVA Fb), the greater the whitening effect. Adding an equal amount of normal fibroblasts to PUVA-treated fibroblasts resulted in a whitening effect greater than that achieved when co-cultured with PUVA Fb alone or when a smaller amount of fibroblasts was added.

[0073] [2-7 Addition of 4-methoxysalicylic acid together with RF irradiation provides further whitening effects] Fibroblasts 3 days after PUVA treatment and untreated fibroblasts were mixed at a ratio of 10:1 and then incubated in dH 2 0 or 1.0% 4-methoxysalicylic acid was applied to the epidermis. RF was irradiated only to the fibroblasts once every three days, and after the culture was completed, the color of the model was evaluated visually and by melanin quantification (Figures 8-1 and 8-2). Further whitening effects were observed with the addition of 4-methoxysalicylic acid in conjunction with RF irradiation. While RF irradiation reduced the number of senescent fibroblasts, the combined application of 4-methoxysalicylic acid appears to have further enhanced the whitening effect by addressing both the epidermis and dermis.

[0074] [2-8 RF irradiation does not excessively increase the temperature of ex vivo fresh skin] Fresh skin (NSA11) was purchased from Genoskin. 1 mL of PBS containing the photosensitizer psoralen (final concentration 0.5 μg / mL) was added to the top and the skin was left in an incubator for 30 minutes, after which the solution was removed with a cotton swab. RF irradiation was then performed at 6 J / cm. 2The tissue was then exposed to UVA radiation (hereafter referred to as PUVA treatment) and further incubated for 24 hours. RF irradiation (RF+: frequency 1 MHz, voltage 70 Vpp; RF++: frequency 950 kHz, voltage 168 Vpp) was performed using two types of high-frequency devices connected to electrodes set at 3 mm width, and stimulation was applied from the upper surface of the skin for 3 minutes. During irradiation, images were taken with a thermographic camera (Optris) and temperature distribution images were obtained using the accompanying software PIX Connect (Figures 9-1 and 9-2). Even after 3 minutes of continuous stimulation with either RF+ or RF++, no excessive temperature rise was observed, and it was revealed that both temperatures were maintained below 40°C.

[0075] [2-9 Even in ex vivo fresh skin, RF irradiation and the addition of 4-methoxysalicylic acid have a further whitening effect] After RF irradiation, the control dH 2 0 or 4-methoxysalicylic acid was added to the top and incubated for another 24 hours. This RF irradiation and extract addition was repeated for three days, after which skin samples were collected. The color of the skin samples was visually observed (Figure 10). As with the 3D model in Figure 8-1, RF irradiation and the addition of 4-methoxysalicylic acid were found to have a further whitening effect in ex vivo fresh skin.

[0076] [2-10 Combining RF irradiation and 4-methoxysalicylic acid has a whitening effect on the epidermis and dermis.] Skin samples were fixed overnight in 4% PFA at 4°C and embedded in paraffin. Paraffin sections (5 μm) were prepared, deparaffinized, and then Fontana-Masson stained. After immersion in Fontana ammoniacal silver solution (Muto Chemical) for 1 hour, they were then immersed in 0.2% gold chloride (Muto Chemical) for 5 seconds to stain melanin. After mounting, the sections were photographed and visualized to confirm changes in the localization and quantity of melanin with and without stimulation (Figure 11-2). PUVA treatment induced darkening of the control due to fibroblast senescence (Figure 11-1, upper left). Addition of 4-methoxysalicylic acid reduced epidermal melanin (Figure 11-1, upper right). The combined use of 4-methoxysalicylic acid and RF irradiation resulted in a reduction in epidermal melanin and senescent fibroblasts compared to the control (Figure 11-1, bottom left and bottom right). It was also confirmed that the combination of RF irradiation and 4-methoxysalicylic acid in ex vivo fresh skin resulted in a whitening effect in the epidermis and dermis due to a reduction in epidermal melanin and senescent fibroblasts.

[0077] [Summary of Experimental Results] The results of the above experiments demonstrated that the application of high frequency waves is effective in inhibiting and improving age spots, i.e., in whitening the skin, and is particularly effective against aging cells. Furthermore, it was found that applying a composition containing 4-methoxysalicylic acid to the skin and applying high frequency waves is effective in inhibiting and improving age spots, particularly in whitening the epidermis and dermis.

[0078] 1 high frequency device 10 electrode portion 10a first electrode 10b second electrode 20 control circuit

Claims

1. A composition for whitening the epidermis and dermis of the skin, which contains 4-methoxysalicylic acid as an active ingredient and is used in combination with a high-frequency treatment device.

2. The composition according to claim 1, wherein the whitening in the dermis is due to a reduction in the number of senescent fibroblasts and / or an increase in the number of normal fibroblasts.

3. The composition according to claim 1 or 2, wherein the high frequency is 0.5 to 4 MHz.

4. The composition according to claim 1 or 2, wherein the high frequency peak-to-peak voltage is 30 to 200 Vpp.

5. A cosmetic method for whitening the epidermis and dermis of the skin, comprising: 1) applying to the skin a composition comprising 4-methoxysalicylic acid; and 2) applying radio frequency waves to the skin.

6. The method according to claim 5, wherein the whitening in the dermis is due to a reduction in the number of senescent fibroblasts and / or an increase in the number of normal fibroblasts.

7. The method according to claim 5 or 6, wherein the frequency of the high frequency is 0.5 to 4 MHz.

8. The method according to claim 5 or 6, wherein the peak-to-peak voltage of the high frequency is 30 to 200 Vpp.

9. A radio frequency cosmetic treatment device for use in a method for whitening the skin, comprising applying to the skin a composition containing 4-methoxysalicylic acid and applying radio frequency to the skin, the radio frequency cosmetic treatment device having a pair of electrodes and a control circuit for applying a radio frequency voltage to the pair of electrodes, the radio frequency cosmetic treatment device being configured to apply the radio frequency voltage to the skin.

10. A beauty kit for whitening, comprising a beauty composition containing 4-methoxysalicylic acid and a radio frequency beauty treatment device.

Citation Information

Patent Citations

  • Skin beautifying device

    JP2004255018A

  • Skin care or beauty system using ion introducer, ultrasonic wave facial treatment device, and cosmetic additives

    JP2005245521A

  • Cosmetic liquid agent penetrating apparatus and method

    JP2007319474A

  • Composition for use in voltage application cosmetic treatment, cosmetic sheet, cosmetic treatment device, and cosmetic method

    WO2022191146A1

  • Composition for external preparation for skin

    WO2023085128A1